Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
Add more filters










Publication year range
1.
Int J Mol Sci ; 23(3)2022 Feb 07.
Article in English | MEDLINE | ID: mdl-35163796

ABSTRACT

Developmental neurotoxicity (DNT) of chemical compounds disrupts the formation of a normal brain. There is impressive progress in the development of alternative testing methods for DNT potential in chemicals, some of which also incorporate invertebrate animals. This review briefly touches upon studies on the genetically tractable model organisms of Caenorhabditis elegans and Drosophila melanogaster about the action of specific developmental neurotoxicants. The formation of a functional nervous system requires precisely timed axonal pathfinding to the correct cellular targets. To address this complex key event, our lab developed an alternative assay using a serum-free culture of intact locust embryos. The first neural pathways in the leg of embryonic locusts are established by a pair of afferent pioneer neurons which use guidance cues from membrane-bound and diffusible semaphorin proteins. In a systematic approach according to recommendations for alternative testing, the embryo assay quantifies defects in pioneer navigation after exposure to a panel of recognized test compounds for DNT. The outcome indicates a high predictability for test-compound classification. Since the pyramidal neurons of the mammalian cortex also use a semaphorin gradient for neurite guidance, the assay is based on evolutionary conserved cellular mechanisms, supporting its relevance for cortical development.


Subject(s)
Nervous System/growth & development , Neurotoxicity Syndromes/etiology , Animals , Axon Guidance/drug effects , Disease Models, Animal , Invertebrates , Nervous System/drug effects , Toxicity Tests
2.
Toxicology ; 463: 152991, 2021 11.
Article in English | MEDLINE | ID: mdl-34673133

ABSTRACT

4-Nitrophenol (PNP) has been extensively used in manufacturing for several decades. Its toxic effects on the male reproductive system have been reported, but the underlying mechanisms remain unclear. In this study, we utilized two testicular somatic cell lines (TM3 and TM4 cells) to explore the possible toxic effects of PNP on the male reproductive system. The activity of the cells after exposure to different doses of PNP (0.01, 0.1, 1, 10 and 100 µM) was evaluated. PNP treatment at 10 µM significantly inhibited cell viability, and 10 µM PNP was thus selected for subsequent experiments. Although PNP (10 µM) inhibited cell proliferation, promoted cell apoptosis, and changed the cell cycle distribution and ultrastructure in both types of cells, these effects were more significant in the TM4 cells. In addition, an Agilent mouse mRNA array was used to identify the gene expression differences between the control and PNP (10 µM) exposed TM3 and TM4 cells. The microarray analysis identified 67 and 1372 differentially expressed genes mainly concentrated in endothelial cell morphogenesis and anatomical structure development in TM3 cells and associated with cardiovascular system development and circulatory system development in TM4 cells. Moreover, a pathway analysis revealed that PNP not only predominately affected meiotic recombination and meiosis in TM3 cells, but also influenced axon guidance and developmental biology in TM4 cells. These results suggest that TM3 and TM4 cells exhibit different responses to PNP, which might mediate different toxic mechanisms.


Subject(s)
Leydig Cells/drug effects , Nitrophenols/toxicity , Sertoli Cells/drug effects , Animals , Apoptosis/drug effects , Axon Guidance/drug effects , Cell Line , Cell Survival/drug effects , Dose-Response Relationship, Drug , Gene Expression Regulation/drug effects , Leydig Cells/metabolism , Male , Meiosis/drug effects , Mice , Nitrophenols/administration & dosage , Reproduction/drug effects , Sertoli Cells/metabolism , Testis/cytology , Testis/drug effects
3.
Nat Commun ; 12(1): 2589, 2021 05 10.
Article in English | MEDLINE | ID: mdl-33972524

ABSTRACT

Patients with Tuberous Sclerosis Complex (TSC) show aberrant wiring of neuronal connections formed during development which may contribute to symptoms of TSC, such as intellectual disabilities, autism, and epilepsy. Yet models examining the molecular basis for axonal guidance defects in developing human neurons have not been developed. Here, we generate human induced pluripotent stem cell (hiPSC) lines from a patient with TSC and genetically engineer counterparts and isogenic controls. By differentiating hiPSCs, we show that control neurons respond to canonical guidance cues as predicted. Conversely, neurons with heterozygous loss of TSC2 exhibit reduced responses to several repulsive cues and defective axon guidance. While TSC2 is a known key negative regulator of MTOR-dependent protein synthesis, we find that TSC2 signaled through MTOR-independent RHOA in growth cones. Our results suggest that neural network connectivity defects in patients with TSC may result from defects in RHOA-mediated regulation of cytoskeletal dynamics during neuronal development.


Subject(s)
Axon Guidance/genetics , Induced Pluripotent Stem Cells/metabolism , Nerve Net/metabolism , Neurogenesis/genetics , Neurons/metabolism , Tuberous Sclerosis Complex 2 Protein/metabolism , Tuberous Sclerosis/metabolism , rhoA GTP-Binding Protein/metabolism , Adolescent , Axon Guidance/drug effects , Biopsy , CRISPR-Cas Systems , Cell Line , Ephrins/pharmacology , Fluorescence Resonance Energy Transfer , Haploinsufficiency , Heterozygote , Humans , Male , Myosins/metabolism , Nerve Net/pathology , Neurogenesis/drug effects , Neurons/drug effects , Organoids/cytology , Organoids/metabolism , Protein Biosynthesis/drug effects , Protein Biosynthesis/genetics , Signal Transduction/drug effects , Signal Transduction/genetics , TOR Serine-Threonine Kinases/metabolism , Tuberous Sclerosis/genetics , Tuberous Sclerosis Complex 2 Protein/genetics
4.
Alcohol Clin Exp Res ; 45(5): 979-995, 2021 05.
Article in English | MEDLINE | ID: mdl-33682149

ABSTRACT

BACKGROUND: Fetal alcohol syndrome (FAS) due to gestational alcohol exposure represents one of the most common causes of nonheritable lifelong disability worldwide. In vitro and in vivo models have successfully recapitulated multiple facets of the disorder, including morphological and behavioral deficits, but far less is understood regarding the molecular and genetic mechanisms underlying FAS. METHODS: In this study, we utilized an in vitro human pluripotent stem cell-based (hPSC) model of corticogenesis to probe the effects of early, chronic intermittent alcohol exposure on the transcriptome of first trimester-equivalent cortical neurons. RESULTS: We used RNA sequencing of developing hPSC-derived neurons treated for 50 days with 50 mM ethanol and identified a relatively small number of biological pathways significantly altered by alcohol exposure. These included cell-type specification, axon guidance, synaptic function, and regional patterning, with a notable upregulation of WNT signaling-associated transcripts observed in alcohol-exposed cultures relative to alcohol-naïve controls. Importantly, this effect paralleled a shift in gene expression of transcripts associated with regional patterning, such that caudal forebrain-related transcripts were upregulated at the expense of more anterior ones. Results from H9 embryonic stem cells were largely replicated in an induced pluripotent stem cell line (IMR90-4), indicating that these patterning alterations are not cell line-specific. CONCLUSIONS: We found that a major effect of chronic intermittent alcohol on the developing cerebral cortex is an overall imbalance in regionalization, with enrichment of gene expression related to the production of posterodorsal progenitors and a diminution of anteroventral progenitors. This finding parallels behavioral and morphological phenotypes observed in animal models of high-dose prenatal alcohol exposure, as well as patients with FAS.


Subject(s)
Cell Differentiation/drug effects , Central Nervous System Depressants/pharmacology , Cerebral Cortex/drug effects , Ethanol/pharmacology , Fetal Alcohol Spectrum Disorders/genetics , Gene Expression/drug effects , Transcriptome/drug effects , Wnt Signaling Pathway/drug effects , Axon Guidance/drug effects , Axon Guidance/genetics , Cell Differentiation/genetics , Cerebral Cortex/embryology , Cerebral Cortex/metabolism , Humans , In Vitro Techniques , Neurons/drug effects , Neurons/metabolism , Patch-Clamp Techniques , Pluripotent Stem Cells , Prosencephalon/drug effects , Prosencephalon/embryology , Prosencephalon/metabolism , RNA-Seq , Wnt Signaling Pathway/genetics
5.
Pharmacol Res ; 165: 105460, 2021 03.
Article in English | MEDLINE | ID: mdl-33513357

ABSTRACT

Despite of its high morbidity and mortality, there is still a lack of effective treatment for ischemic stroke in part due to our incomplete understanding of molecular mechanisms of its pathogenesis. In this study, we demonstrate that SHH-PTCH1-GLI1-mediated axonal guidance signaling and its related neurogenesis, a central pathway for neuronal development, also plays a critical role in early stage of an acute stroke model. Specifically, in vivo, we evaluated the effect of GXNI on ischemic stroke mice via using the middle cerebral artery embolization model, and found that GXNI significantly alleviated cerebral ischemic reperfusion (I/R) injury by reducing the volume of cerebral infarction, neurological deficit score and cerebral edema, reversing the BBB permeability and histopathological changes. A combined approach of RNA-seq and network pharmacology analysis was used to reveal the underlying mechanisms of GXNI followed by RT-PCR, immunohistochemistry and western blotting validation. It was pointed out that axon guidance signaling pathway played the most prominent role in GXNI action with Shh, Ptch1, and Gli1 genes as the critical contributors in brain protection. In addition, GXNI markedly prevented primary cortical neuron cells from oxygen-glucose deprivation/reoxygenation damage in vitro, and promoted axon growth and synaptogenesis of damaged neurons, which further confirmed the results of in vivo experiments. Moreover, due to the inhibition of the SHH-PTCH1-GLI1 signaling pathway by cyclopropylamine, the effect of GXNI was significantly weakened. Hence, our study provides a novel option for the clinical treatment of acute ischemic stroke by GXNI via SHH-PTCH1-GLI1-mediated axonal guidance signaling, a neuronal development pathway previously considered for after-stroke recovery.


Subject(s)
Axon Guidance/drug effects , Brain Ischemia/drug therapy , Brain Ischemia/pathology , Drugs, Chinese Herbal/therapeutic use , Ischemic Stroke/drug therapy , Ischemic Stroke/pathology , Animals , Animals, Newborn , Axon Guidance/physiology , Brain Ischemia/metabolism , Cells, Cultured , Dose-Response Relationship, Drug , Drugs, Chinese Herbal/pharmacology , Ischemic Stroke/metabolism , Male , Mice , Mice, Inbred C57BL , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use
6.
Cell Mol Life Sci ; 78(5): 2247-2262, 2021 Mar.
Article in English | MEDLINE | ID: mdl-32939562

ABSTRACT

The neurotransmitter serotonin has been implicated in a range of complex neurological disorders linked to alterations of neuronal circuitry. Serotonin is synthesized in the developing brain before most neuronal circuits become fully functional, suggesting that serotonin might play a distinct regulatory role in shaping circuits prior to its function as a classical neurotransmitter. In this study, we asked if serotonin acts as a guidance cue by examining how serotonin alters growth cone motility of rodent sensory neurons in vitro. Using a growth cone motility assay, we found that serotonin acted as both an attractive and repulsive guidance cue through a narrow concentration range. Extracellular gradients of 50 µM serotonin elicited attraction, mediated by the serotonin 5-HT2a receptor while 100 µM serotonin elicited repulsion mediated by the 5-HT1b receptor. Importantly, high resolution imaging of growth cones indicated that these receptors signalled through their canonical pathways of endoplasmic reticulum-mediated calcium release and cAMP depletion, respectively. This novel characterisation of growth cone motility in response to serotonin gradients provides compelling evidence that secreted serotonin acts at the molecular level as an axon guidance cue to shape neuronal circuit formation during development.


Subject(s)
Cell Movement/drug effects , Growth Cones/drug effects , Sensory Receptor Cells/drug effects , Serotonin/pharmacology , Animals , Axon Guidance/drug effects , Axons/drug effects , Axons/metabolism , Calcium/metabolism , Cells, Cultured , Female , Growth Cones/physiology , Humans , Rats, Sprague-Dawley , Receptor, Serotonin, 5-HT1B , Receptors, Serotonin, 5-HT2 , Sensory Receptor Cells/cytology , Sensory Receptor Cells/metabolism
7.
Arch Toxicol ; 94(12): 4099-4113, 2020 12.
Article in English | MEDLINE | ID: mdl-33079231

ABSTRACT

Exposure to environmental chemicals during in utero and early postnatal development can cause a wide range of neurological defects. Since current guidelines for identifying developmental neurotoxic chemicals depend on the use of large numbers of rodents in animal experiments, it has been proposed to design rapid and cost-efficient in vitro screening test batteries that are mainly based on mixed neuronal/glial cultures. However, cell culture tests do not assay correct wiring of neuronal circuits. The establishment of precise anatomical connectivity is a key event in the development of a functional brain. Here, we expose intact embryos of the locust (Locusta migratoria) in serum-free culture to test chemicals and visualize correct navigation of identified pioneer axons by fluorescence microscopy. We define separate toxicological endpoints for axonal elongation and navigation along a stereotyped pathway. To distinguish developmental neurotoxicity (DNT) from general toxicity, we quantify defects in axonal elongation and navigation in concentration-response curves and compare it to the biochemically determined viability of the embryo. The investigation of a panel of recognized DNT-positive and -negative test compounds supports a rather high predictability of this invertebrate embryo assay. Similar to the semaphorin-mediated guidance of neurites in mammalian cortex, correct axonal navigation of the locust pioneer axons relies on steering cues from members of this family of cell recognition molecules. Due to the evolutionary conserved mechanisms of neurite guidance, we suggest that our pioneer axon paradigm might provide mechanistically relevant information on the DNT potential of chemical agents on the processes of axon elongation, navigation, and fasciculation.


Subject(s)
Axon Guidance/drug effects , Axons/drug effects , Grasshoppers/drug effects , Nervous System/drug effects , Neurotoxicity Syndromes/etiology , Animals , Axons/metabolism , Axons/pathology , Dose-Response Relationship, Drug , Embryo Culture Techniques , Embryo, Nonmammalian/drug effects , Embryo, Nonmammalian/metabolism , Grasshoppers/embryology , Microscopy, Fluorescence , Necrosis , Nervous System/embryology , Nervous System/metabolism , Neurotoxicity Syndromes/metabolism , Neurotoxicity Syndromes/pathology , Toxicity Tests
8.
Adv Biosyst ; 4(3): e1900212, 2020 03.
Article in English | MEDLINE | ID: mdl-32293152

ABSTRACT

A number of natural polymer biomaterial-based nerve guidance conduits (NGCs) are developed to facilitate repair of peripheral nerve injuries. Cross-linking ensures mechanical integrity and desired degradation properties of the NGCs; however, common methods such as formaldehyde are associated with cellular toxicity. Hence, there is an unmet clinical need for alternative nontoxic cross-linking agents. In this study, collagen-based NGCs with a collagen/chondroitin sulfate luminal filler are used to study the effect of cross-linking on mechanical and structural properties, degradation, biocompatibility, and immunological response. A simplified manufacturing method of genipin cross-linking is developed, by incorporating genipin into solution prior to freeze-drying the NGCs. This leads to successful cross-linking as demonstrated by higher cross-linking degree and similar tensile strength of genipin cross-linked conduits compared to formaldehyde cross-linked conduits. Genipin cross-linking also preserves NGC macro and microstructure as observed through scanning electron microscopy and spectral analysis. Most importantly, in vitro cell studies show that genipin, unlike the formaldehyde cross-linked conduits, supports the viability of Schwann cells. Moreover, genipin cross-linked conduits direct macrophages away from a pro-inflammatory and toward a pro-repair state. Overall, genipin is demonstrated to be an effective, safe, biocompatible, and anti-inflammatory alternative to formaldehyde for cross-linking clinical grade NGCs.


Subject(s)
Anti-Inflammatory Agents , Axon Guidance/drug effects , Cross-Linking Reagents , Iridoids , Tissue Scaffolds/chemistry , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Biocompatible Materials/chemistry , Biocompatible Materials/pharmacology , Cell Line , Cross-Linking Reagents/chemistry , Cross-Linking Reagents/pharmacology , Fibroblasts/cytology , Humans , Iridoids/chemistry , Iridoids/pharmacology , Rats , Schwann Cells/cytology , Tissue Engineering
10.
ACS Chem Neurosci ; 11(2): 121-132, 2020 01 15.
Article in English | MEDLINE | ID: mdl-31825204

ABSTRACT

A spinal cord injury can damage neuronal connections required for both motor and sensory function. Barriers to regeneration within the central nervous system, including an absence of neurotrophic stimulation, impair the ability of injured neurons to reestablish their original circuitry. Exogenous neurotrophin administration has been shown to promote axonal regeneration and outgrowth following injury. The neurotrophins possess chemotrophic properties that guide axons toward the region of highest concentration. These growth factors have demonstrated potential to be used as a therapeutic intervention for orienting axonal growth beyond the injury lesion, toward denervated targets. However, the success of this approach is dependent on the appropriate spatiotemporal distribution of these molecules to ensure detection and navigation by the axonal growth cone. A number of in vitro gradient-based assays have been employed to investigate axonal response to neurotrophic gradients. Such platforms have helped elucidate the potential of applying a concentration gradient of neurotrophins to promote directed axonal regeneration toward a functionally significant target. Here, we review these techniques and the principles of gradient detection in axonal guidance, with particular focus on the use of neurotrophins to orient the trajectory of regenerating axons.


Subject(s)
Axon Guidance/drug effects , In Vitro Techniques , Nerve Growth Factors/pharmacology , Nerve Regeneration/drug effects , Spinal Cord Injuries , Animals , Humans
11.
Neurotoxicol Teratol ; 74: 106812, 2019.
Article in English | MEDLINE | ID: mdl-31251980

ABSTRACT

BACKGROUND: General anesthetics (GAs) may exert harmful effects on the developing brain by disrupting neuronal circuit formation. Anesthetics that act on γ-aminobutyric acid (GABA) receptors can interfere with axonal growth cone guidance, a critical process in the assembly of neuronal circuitry. Here we investigate the mechanism by which isoflurane prevents sensing of the repulsive guidance cue, Semaphorin 3A (Sema3A). METHODS: Growth cone sensing was assayed by measuring growth cone collapse in dissociated neocortical cultures exposed to recombinant Sema3A in the presence or absence of isoflurane and/or a panel of reagents with specific actions on components of the GABA receptor and chloride ion systems. RESULTS: Isoflurane exposure prevents Sema3A induced growth cone collapse. A GABAA α2 specific agonist replicates this effect (36.83 ±â€¯3.417% vs 70.82 ±â€¯2.941%, in the Sema3A induced control group, p < 0.0001), but an α1-specific agonist does not. Both a Na-K-Cl cotransporter 1 antagonism (bumetanide, BUM) and a chloride ionophore (IONO) prevent isoflurane from disrupting growth cone sensing of Sema3A. (65.67 ±â€¯3.775% in Iso + BUM group vs 67.45 ±â€¯3.624% in Sema3A induced control group, 65.34 ±â€¯1.678% in Iso + IONO group vs 68.71 ±â€¯2.071% in Sema3A induced control group, no significant difference) (n = 96 growth cones per group). CONCLUSION: Our data suggest that the effects of isoflurane on growth cone sensing are mediated by the α2 subunit of the GABAA receptor and also that they are dependent on the developmental chloride gradient, in which Cl- exhibits a depolarizing effect. These findings provide a rationale for why immature neurons are particularly susceptible to anesthetic toxicity.


Subject(s)
Anesthetics, Inhalation/pharmacology , Axon Guidance/drug effects , Chlorides/metabolism , Growth Cones/drug effects , Isoflurane/pharmacology , Receptors, GABA-A/metabolism , Semaphorin-3A/metabolism , Animals , Growth Cones/metabolism , Primary Cell Culture , Rats, Sprague-Dawley
12.
Neuroimage ; 195: 243-251, 2019 07 15.
Article in English | MEDLINE | ID: mdl-30953832

ABSTRACT

In autism spectrum disorder (ASD), disrupted functional and structural connectivity in the social brain has been suggested as the core biological mechanism underlying the social recognition deficits of this neurodevelopmental disorder. In this study, we aimed to identify genetic and neurostructural abnormalities at birth in a non-human primate model of ASD, the common marmoset with maternal exposure to valproic acid (VPA), which has been reported to display social recognition deficit in adulthood. Using a comprehensive gene expression analysis, we found that 20 genes were significantly downregulated in VPA-exposed neonates. Of these, Frizzled3 (FZD3) and PIK3CA were identified in an axon guidance signaling pathway. FZD3 is essential for the normal development of the anterior commissure (AC) and corpus callosum (CC); hence, we performed diffusion tensor magnetic resonance imaging with a 7-Tesla scanner to measure the midsagittal sizes of these structures. We found that the AC size in VPA-exposed neonates was significantly smaller than that in age-matched controls, while the CC size did not differ. These results suggest that downregulation of the genes related to axon guidance and decreased AC size in neonatal primates may be linked to social brain dysfunctions that can happen later in life.


Subject(s)
Anterior Commissure, Brain/pathology , Autism Spectrum Disorder/pathology , Axon Guidance/physiology , Animals , Animals, Newborn , Autism Spectrum Disorder/chemically induced , Autism Spectrum Disorder/metabolism , Axon Guidance/drug effects , Callithrix , Class I Phosphatidylinositol 3-Kinases/biosynthesis , Disease Models, Animal , Frizzled Receptors/biosynthesis , GABA Agents/toxicity , Transcriptome/drug effects , Valproic Acid/toxicity
13.
J Cell Sci ; 132(9)2019 04 30.
Article in English | MEDLINE | ID: mdl-30890650

ABSTRACT

It has long been established that neuronal growth cone navigation depends on changes in microtubule (MT) and F-actin architecture downstream of guidance cues. However, the mechanisms by which MTs and F-actin are dually coordinated remain a fundamentally unresolved question. Here, we report that the well-characterized MT polymerase, XMAP215 (also known as CKAP5), plays an important role in mediating MT-F-actin interaction within the growth cone. We demonstrate that XMAP215 regulates MT-F-actin alignment through its N-terminal TOG 1-5 domains. Additionally, we show that XMAP215 directly binds to F-actin in vitro and co-localizes with F-actin in the growth cone periphery. We also find that XMAP215 is required for regulation of growth cone morphology and response to the guidance cue, Ephrin A5. Our findings provide the first strong evidence that XMAP215 coordinates MT and F-actin interaction in vivo We suggest a model in which XMAP215 regulates MT extension along F-actin bundles into the growth cone periphery and that these interactions may be important to control cytoskeletal dynamics downstream of guidance cues. This article has an associated First Person interview with the first author of the paper.


Subject(s)
Actins/metabolism , Axons/metabolism , Growth Cones/metabolism , Microtubule-Associated Proteins/metabolism , Microtubules/metabolism , Xenopus Proteins/metabolism , Actin Cytoskeleton/metabolism , Animals , Axon Guidance/drug effects , Ephrin-A5/pharmacology , Xenopus laevis/embryology , Xenopus laevis/metabolism
14.
Dev Cell ; 46(4): 410-425.e7, 2018 08 20.
Article in English | MEDLINE | ID: mdl-30078728

ABSTRACT

In the developing spinal cord, Sonic hedgehog (Shh) attracts commissural axons toward the floorplate. How Shh regulates the cytoskeletal remodeling that underlies growth cone turning is unknown. We found that Shh-mediated growth cone turning requires the activity of Docks, which are unconventional GEFs. Knockdown of Dock3 and 4, or their binding partner ELMO1 and 2, abolished commissural axon attraction by Shh in vitro. Dock3/4 and ELMO1/2 were also required for correct commissural axon guidance in vivo. Polarized Dock activity was sufficient to induce axon turning, indicating that Docks are instructive for axon guidance. Mechanistically, we show that Dock and ELMO interact with Boc, the Shh receptor, and that this interaction is reduced upon Shh stimulation. Furthermore, Shh stimulation translocates ELMO to the growth cone periphery and activates Rac1. This identifies Dock/ELMO as an effector complex of non-canonical Shh signaling and demonstrates the instructive role of GEFs in axon guidance.


Subject(s)
Axon Guidance/drug effects , Axons/drug effects , Gene Expression Regulation, Developmental/drug effects , Guanine Nucleotide Exchange Factors/metabolism , Hedgehog Proteins/pharmacology , Adaptor Proteins, Signal Transducing/genetics , Animals , Carrier Proteins/genetics , Cells, Cultured , Cytoskeletal Proteins/genetics , Embryo, Mammalian/metabolism , GTPase-Activating Proteins/genetics , Gene Expression Regulation, Developmental/genetics , Growth Cones/drug effects , Growth Cones/metabolism , Hedgehog Proteins/metabolism , Mice, Transgenic , Nerve Tissue Proteins/genetics , Neurons/metabolism , Spinal Cord/metabolism
15.
Neurotoxicology ; 68: 91-100, 2018 09.
Article in English | MEDLINE | ID: mdl-30031110

ABSTRACT

Oxaliplatin is a platinum-based drug used in the treatment of gastric cancers. Oxaliplatin treatment induces sensory neuropathy characterized by cold hypersensibility in the acute phase and sensory impairment when the neuropathy becomes chronic. In order to determine the effect of oxaliplatin on sensory neurons, we used an in vitro model in which oxaliplatin treatment reduced arborization of dorsal root ganglia neurons in a dose-dependent manner. Moreover, we characterized the role of microRNAs in oxaliplatin induced-neuropathy. In particular, we focused on microRNAs that control the expression of axon guidance molecules, and therefore, regulate neurite arborization. As a result, we highlighted the upregulation of miR-204, a microRNA that controls the expression of PlexinA2, a semaphorin receptor involved in neurite guidance. Interaction of miR-204 and Plexin A2 was confirmed by luciferase assay. In addition, overexpression of miR-204 in dorsal root ganglia neuron cultures reduced length and extension of neurites and also reduced Plexin A2 labelling without increasing apoptosis rate. On the other hand, sequestration of miR-204 by a specific microRNA sponge increases neurite length and PlexinA2 expression. Taken together, our data indicate that oxaliplatin impairs sensory neurons arborization through up-regulation of miR-204 that decreases PlexinA2 expression and neurite length.


Subject(s)
MicroRNAs/metabolism , Neurites/drug effects , Neurites/metabolism , Oxaliplatin/pharmacology , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/metabolism , Animals , Axon Guidance/drug effects , Female , Ganglia, Spinal/drug effects , Ganglia, Spinal/metabolism , Male , Mice, Inbred C57BL , Nerve Tissue Proteins/metabolism , Primary Cell Culture , Receptors, Cell Surface/metabolism
16.
J Cell Biol ; 217(3): 1113-1128, 2018 03 05.
Article in English | MEDLINE | ID: mdl-29351997

ABSTRACT

Neurite elongation and branching in developing neurons requires plasmalemma expansion, hypothesized to occur primarily via exocytosis. We posited that exocytosis in developing neurons and nonneuronal cells would exhibit distinct spatiotemporal organization. We exploited total internal reflection fluorescence microscopy to image vesicle-associated membrane protein (VAMP)-pHluorin-mediated exocytosis in mouse embryonic cortical neurons and interphase melanoma cells, and developed computer-vision software and statistical tools to uncover spatiotemporal aspects of exocytosis. Vesicle fusion behavior differed between vesicle types, cell types, developmental stages, and extracellular environments. Experiment-based mathematical calculations indicated that VAMP2-mediated vesicle fusion supplied excess material for the plasma membrane expansion that occurred early in neuronal morphogenesis, which was balanced by clathrin-mediated endocytosis. Spatial statistics uncovered distinct spatiotemporal regulation of exocytosis in the soma and neurites of developing neurons that was modulated by developmental stage, exposure to the guidance cue netrin-1, and the brain-enriched ubiquitin ligase tripartite motif 9. In melanoma cells, exocytosis occurred less frequently, with distinct spatial clustering patterns.


Subject(s)
Exocytosis/physiology , Neurites/physiology , Neurogenesis , Neurons/physiology , Animals , Axon Guidance/drug effects , Axon Guidance/physiology , Carrier Proteins/genetics , Cell Line, Tumor , Cell Shape , Clathrin/genetics , Clathrin/metabolism , Exocytosis/drug effects , HEK293 Cells , Humans , Image Processing, Computer-Assisted , Mice , Mice, Knockout , Nerve Tissue Proteins/genetics , Netrin-1/pharmacology , Neurites/drug effects , Neurons/cytology , Neurons/drug effects , Primary Cell Culture , Software , Ubiquitin-Protein Ligases , Vesicle-Associated Membrane Protein 2/metabolism
17.
Cell Mol Neurobiol ; 38(3): 703-713, 2018 Apr.
Article in English | MEDLINE | ID: mdl-28823058

ABSTRACT

The current study aimed to enhance the efficacy of peripheral nerve regeneration using a biodegradable porous neural guidance conduit as a carrier to transplant allogeneic Schwann cells (SCs). The conduit was prepared from polyurethane (PU) and gelatin nanofibrils (GNFs) using thermally induced phase separation technique and filled with melatonin (MLT) and platelet-rich plasma (PRP). The prepared conduit had the porosity of 87.17 ± 1.89%, the contact angle of 78.17 ± 5.30° and the ultimate tensile strength and Young's modulus of 5.40 ± 0.98 MPa and 3.13 ± 0.65 GPa, respectively. The conduit lost about 14% of its weight after 60 days in distilled water. The produced conduit enhanced the proliferation of SCs demonstrated by a tetrazolium salt-based assay. For functional analysis, the conduit was seeded with 1.50 × 104 SCs (PU/GNFs/PRP/MLT/SCs) and implanted into a 10-mm sciatic nerve defect of Wistar rat. Three control groups were used: (1) PU/GNFs/SCs, (2) PU/GNFs/PRP/SCs, and (3) Autograft. The results of sciatic functional index, hot plate latency, compound muscle action potential amplitude and latency, weight-loss percentage of wet gastrocnemius muscle and histopathological examination using hematoxylin-eosin and Luxol fast blue staining, demonstrated that using the PU/GNFs/PRP/MLT conduit to transplant SCs to the sciatic nerve defect resulted in a higher regenerative outcome than the PU/GNFs and PU/GNFs/PRP conduits.


Subject(s)
Gelatin/pharmacology , Platelet-Rich Plasma/drug effects , Polyurethanes/pharmacology , Schwann Cells/drug effects , Animals , Axon Guidance/drug effects , Melatonin/metabolism , Melatonin/pharmacology , Nerve Regeneration/drug effects , Rats, Wistar , Schwann Cells/cytology , Sciatic Nerve/drug effects , Sciatic Nerve/pathology
18.
J Tissue Eng Regen Med ; 12(1): 70-79, 2018 01.
Article in English | MEDLINE | ID: mdl-27863093

ABSTRACT

Establishing appropriate synaptic connections and plasticity is a critical need in neuronal regeneration and development. Mechano growth factor (MGF) and its C-terminal E-domain peptide with 24 amino acids, MGF-Ct24E, are potential neuroprotective agents. Our preliminary study indicates that Netrin-1 can guide axonal growth and its expression is sensitive to MGF, but how MGF regulates the expression of Netrin-1 and its receptor DCC is still unclear. Here, we investigate the effect of MGF-Ct24E on the expression of Netrin-1 and DCC in primary cultured cortical neurons in vitro and the adult rat brain in vivo. MTT assay shows that MGF-Ct24E can significantly protect primary cortical neurons against nerve injury. There is a significant increase in axonal elongation after MGF-Ct24E treatment at concentrations of 0.5 and 1.0 µg/ml. Real-time polymerase chain reaction assay indicates that MGF-Ct24E can effectively promote the expression of Netrin-1 and DCC in primary cultured cortical neurons. To identify the certain mechanism of MGF-Ct24E on neuronal guidance and growth, adult rats are subjected to intramuscular injection of MGF-Ct24E after traumatic brain injury. Rats injected with MGF-Ct24E start eating and drinking within 14 days, indicating that MGF-Ct24E can promote rehabilitation. HE staining and immunohistochemistry assays of brain section slices reveal that MGF-Ct24E treatment can significantly inhibit the haemorrhage of traumatic brain injury and promote expression of Netrin-1. Further investigation of protein expression by Western blot assay shows that MGF-Ct24E promotes expression of Netrin-1 and DCC after nerve injury. MGF-Ct24E can effectively improve axonal guidance through upregulation of Netrin-1/DCC signalling in neuronal regeneration. Copyright © 2016 John Wiley & Sons, Ltd.


Subject(s)
Axon Guidance/drug effects , Cerebral Cortex/cytology , Insulin-Like Growth Factor I/pharmacology , Neurons/metabolism , Peptides/pharmacology , Aging , Animals , Brain Injuries, Traumatic/pathology , Cell Survival/drug effects , Cells, Cultured , Doublecortin Domain Proteins , Intermediate Filaments/metabolism , Microtubule-Associated Proteins/metabolism , Nerve Tissue/drug effects , Nerve Tissue/injuries , Nerve Tissue/pathology , Netrin-1/metabolism , Neurons/drug effects , Neuropeptides/metabolism , Protective Agents/pharmacology , Rats, Sprague-Dawley
19.
Int J Dev Neurosci ; 66: 24-32, 2018 May.
Article in English | MEDLINE | ID: mdl-29196093

ABSTRACT

Previous studies have demonstrated that both Wnt5a and Sonic hedgehog (Shh) are involved in regulating the pathfinding of descending serotonergic (5-HT, 5-hydroxytryptamine) axons in an opposite manner in the brainstem. Shh and Wnt signaling pathways interact to guide post-crossing commissural axons, where Shh acts as a repellent directly and shaping the Wnt gradient indirectly by regulating the gradient expression of the frizzled-related protein 1 (Sfrp1). Whether such a mechanism functions in descending 5-HT axon guidance remains unknown. Here, we found that the core components of the Shh and Wnt planar cell polarity signaling pathways are expressed in caudal 5-HT neurons, and the expression gradients of Shh, Sfrp1, and Wnt5a exist simultaneously in hindbrain. Dunn chamber assays revealed that Sfrp1 suppressed the attractive Wnt gradient. Moreover, we found that Shh overexpression led to pathfinding defects in 5-HT axon descending, and the axonal pathfinding defects could be partially rescued by administration of an Sfrp1 antagonist in vivo. Biochemical evidence showed Shh overexpression upregulated the expression of the Sfrp1 gene and interrupted Wnt5a binding to Frizzled-3. Taken together, our results indicate that Shh, Sfrp1, and Wnt5a collaborate to direct the pathfinding of descending 5-HT axons in the brainstem.


Subject(s)
Axon Guidance/genetics , Hedgehog Proteins/metabolism , Proteins/metabolism , Rhombencephalon/cytology , Serotonergic Neurons/cytology , Wnt-5a Protein/metabolism , Animals , Axon Guidance/drug effects , Cells, Cultured , Electroporation , Embryo, Mammalian , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Developmental/genetics , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Hedgehog Proteins/genetics , Immunoprecipitation , Intercellular Signaling Peptides and Proteins/metabolism , Intracellular Signaling Peptides and Proteins , Membrane Proteins/antagonists & inhibitors , Membrane Proteins/metabolism , Mice , Morpholines/pharmacology , Patched-1 Receptor/metabolism , Proteins/genetics , Pyridines/pharmacology , Serotonergic Neurons/drug effects , Serotonin/metabolism , Wnt-5a Protein/genetics
20.
J Biomed Mater Res B Appl Biomater ; 106(4): 1463-1476, 2018 05.
Article in English | MEDLINE | ID: mdl-28675568

ABSTRACT

The current study aimed to enhance the efficacy of peripheral nerve regeneration using an electrically conductive biodegradable porous neural guidance conduit for transplantation of allogeneic Schwann cells (SCs). The conduit was produced from polylactic acid (PLA), multiwalled carbon nanotubes (MWCNTs), and gelatin nanofibrils (GNFs) coated with the recombinant human erythropoietin-loaded chitosan nanoparticles (rhEpo-CNPs). The PLA/MWCNTs/GNFs/rhEpo-CNPs conduit had the porosity of 85.78 ± 0.70%, the contact angle of 77.65 ± 1.91° and the ultimate tensile strength and compressive modulus of 5.51 ± 0.13 MPa and 2.66 ± 0.34 MPa, respectively. The conduit showed the electrical conductivity of 0.32 S cm-1 and lost about 11% of its weight after 60 days in normal saline. The produced conduit was able to release the rhEpo for at least 2 weeks and exhibited favorable cytocompatibility towards SCs. For functional analysis, the conduit was seeded with 1.5 × 104 SCs and implanted into a 10 mm sciatic nerve defect of Wistar rat. After 14 weeks, the results of sciatic functional index, hot plate latency, compound muscle action potential amplitude, weight-loss percentage of wet gastrocnemius muscle and Histopathological examination using hematoxylin-eosin and Luxol fast blue staining demonstrated that the produced conduit had comparable nerve regeneration to the autograft, as the gold standard to bridge the nerve gaps. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1463-1476, 2018.


Subject(s)
Axon Guidance/drug effects , Erythropoietin , Gelatin/chemistry , Nanotubes, Carbon/chemistry , Nerve Regeneration/drug effects , Schwann Cells/transplantation , Sciatic Nerve , Allografts , Animals , Chitosan/chemistry , Delayed-Action Preparations/chemistry , Delayed-Action Preparations/pharmacokinetics , Delayed-Action Preparations/pharmacology , Erythropoietin/chemistry , Erythropoietin/pharmacokinetics , Erythropoietin/pharmacology , Male , Porosity , Rats , Rats, Wistar , Schwann Cells/metabolism , Sciatic Nerve/injuries , Sciatic Nerve/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...